INVESTORS & MEDIA
News Release
Regeneron Announces Presentation at the 36th Annual J.P. Morgan Healthcare Conference
About Regeneron
Regeneron is accelerating and improving the traditional drug development process through its proprietary VelociSuite® technologies, including VelocImmune® to yield optimized fully-human antibodies, and ambitious initiatives such as the Regeneron Genetics Center, one of the largest genetics sequencing efforts in the world.
For additional information about the company, please visit www.regeneron.com or follow @Regeneron on Twitter.
Contact Information: |
|
Investor Relations |
Corporate Communications |
|
|
914.847.5126 |
914.847.3422 |
View original content:http://www.prnewswire.com/news-releases/regeneron-announces-presentation-at-the-36th-annual-jp-morgan-healthcare-conference-300573414.html
SOURCE
News Provided by Acquire Media